The ambition to turn the Oxford–Cambridge corridor into “Europe’s Silicon Valley” is in danger of stalling unless the ...

Sanofi has agreed to acquire hepatitis B vaccine manufacturer Dynavax for an equity value of around $2.2bn, bolstering the ...

Matthew Herper covers medical innovation — both its promise and its perils. It has been a tough year for medicine. The U.S.

British firms are losing their dominance in Kenya as Asian and African players rise, marked by Diageo’s $3bn sale of EABL and ...

Domestic pharmaceutical and biotech companies’ technology export volume exceeded 20 trillion Korean won this year, marking a ...

The airstrikes, which came early Tuesday morning local time, mark the second time in a week that the Saudis have struck the Southern Transitional Council, a Yemeni militia backed by the U.A.E. that ...

Throughout 2025, Midas has unearthed the little-known companies that hold great potential and the bigger beasts we feel have ...

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President ...

Axonal.AI distinguishes itself from the current wave of generative AI chatbots by positioning itself as an enterprise-native operating layer. While standard LLMs often hallucinate or prioritize ...

President Trump’s anti-LGBTQ agenda dominated national news in 2025, particularly his cruel attacks on trans Americans. Here are our picks for the top 10 LGBTQ news stories the Blade covered in 2025.

Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...

Today, China ranks second only to the United States in the number of new drugs under development, with its pipeline ...